Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00492687
Title Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors San Diego Pacific Oncology & Hematology Associates
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.